Optimize
← All biomarkers
Immune System

Monocytes

White blood cells that are part of the innate immune system.

What is Monocytes?

Monocytes are large mononuclear white blood cells circulating in the blood as part of innate immunity. They normally make up 2–8% of the total leukocyte count, corresponding to an absolute count of 0.2–1.0 ×10⁹/L in adults. Produced in the bone marrow, they circulate briefly (on average 1–3 days) before migrating into tissues, where they mature into macrophages or dendritic cells. Macrophages are the major scavengers of the immune system: they phagocytose pathogens, dead cells, and debris; present antigens to T cells; and orchestrate the local inflammatory response through cytokines. An elevated monocyte count (monocytosis, absolute > 1.0 ×10⁹/L) can occur with bacterial infections — particularly tuberculosis and brucellosis —, chronic inflammation (Crohn's disease, rheumatoid arthritis, sarcoidosis), recovery after an acute infection, and myeloid malignancies such as chronic myelomonocytic leukaemia (CMML). Monocytes also play a direct role in atherosclerosis: activated monocytes that enter the artery wall become macrophages, ingest oxidised LDL, and form foam cells that contribute to plaque formation — explaining the association between chronically elevated monocyte counts and cardiovascular disease. A low monocyte count (monocytopaenia) is rarer and can occur with aplastic bone marrow, high-dose corticosteroids, or certain haematological conditions. In clinical practice, an isolated mild monocytopaenia rarely carries immediate significance, but combined with a low total leukocyte count further evaluation is warranted.

Why is Monocytes relevant?

Monocytes are clinically relevant as a broad indicator of immune activity. A transient monocytosis immediately after an infection is a normal recovery response in which the bone marrow ramps up production to replenish tissue macrophages. A persistent monocytosis without a recent infection or inflammatory context warrants more attention: an absolute monocyte count above 1.5 ×10⁹/L confirmed on two separate measurements in an adult without an identifiable cause makes CMML the leading haematological consideration. For people who regularly face high physical or psychological stress, the monocyte count moves as part of the broader leukocyte shift. Acutely, monocytes rise alongside neutrophils during intense exercise; chronically, a mildly elevated count can reflect low-grade systemic inflammation — context that is better weighed alongside CRP or hsCRP. Monocytes also carry relevance in the assessment of inflammatory bowel disease, sarcoidosis, and rheumatoid arthritis: in active disease, monocyte counts and the ratio of classical to non-classical monocytes are elevated and can track disease activity. As a routine standalone measure of disease activity they are rarely used in isolation — they are more a supplementary piece in the clinical picture.

Monocytes high or low — what it means

Monocytes are almost always read as part of the leukocyte differential — alongside total leukocytes, neutrophils, lymphocytes, eosinophils, and basophils. The absolute count in ×10⁹/L is more informative than the percentage, because the percentage depends on the proportion relative to other cell types. An isolated mildly elevated monocyte count with an otherwise normal blood count in a clinically quiet period calls for repeat testing, not immediate action. With a persistently elevated absolute count — above 1.0 ×10⁹/L across multiple measurements and without an identifiable infectious or inflammatory cause — additional steps are warranted: LDH, uric acid, a peripheral blood smear review, and where CMML is suspected, haematological follow-up. CRP helps support or refute infection or inflammation as the cause. A steadily rising trend is more informative than one isolated high value. Acute infections — particularly bacterial or mycobacterial — classically produce a combination of neutrophilia and monocytosis. Chronic inflammation tends to give a subtler, sustained elevation. Trends across multiple measurements under comparable conditions are more reliable than a single reading, particularly when the clinical context shifts between tests.

Educational information only — not medical advice. Consult a healthcare professional for clinical decisions.

Read about our scientific approach

Monocytes is one of the biomarkers in the Optimize test panel. Book a blood draw at any of 238+ partner labs in the Netherlands, or upload your existing results in the app.

See the full panel